Pharmacokinetics of Levodopa After Repeated Doses of Different Pellet Formulations; An Open, Randomized Study With Crossover Design in Healthy Male Subjects
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 02 Aug 2017
At a glance
- Drugs Levodopa (Primary) ; ODM 104 (Primary) ; Carbidopa
- Indications Parkinson's disease
- Focus Pharmacokinetics
- Sponsors Orion
- 28 Jul 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jul 2017.
- 28 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 09 May 2017 New trial record